Media may degrade due to temperature extremes during shipping, invalidating manufacturer QC.

Dehydration or moisture loss during transit.

Importantly, M22‑A3 defines a for commercially prepared culture media. This limit is a critical benchmark that manufacturers and laboratories must monitor during production, transport, storage, and handling to ensure media integrity.

As of 2025, M22-A3 remains the active standard. However, clinical chromatography is evolving:

Guidance on what to do when media fails QC: quarantining the lot, notifying the manufacturer, and deciding whether to use alternative media.

Commercial media producers must adhere to stringent quality management systems (such as ISO 13485) and perform rigorous testing on every batch, including: Ensuring no baseline contamination.

If you are hunting for a to review its structure, here is a chapter-by-chapter breakdown of what the official document contains.

International standards for medical laboratory quality management systems emphasize the need for robust reagent and media verification protocols. Practical Steps for Laboratory Integration

Upon receipt of every shipment, laboratory personnel must visually inspect the media for: Visible mold or bacterial colonies.

While commercial manufacturers perform the bulk of the testing, the clinical laboratory remains ultimately responsible for the quality of the media used in patient testing. Laboratories must: Verify that shipments arrive at the correct temperature.

The first step is to check the manufacturer’s labeling and then consult . This table contains the central list of all commercial media covered by the document.

The Clinical and Laboratory Standards Institute (CLSI) is a non-profit organization that develops standards through global consensus. Because generating these standards requires immense research and expert collaboration, CLSI operates on a paid-access model.

Keep the manufacturer’s QC certificates on file for inspection.